Dumith Chequer Bou‐Habib
- Virology top 1%
- HIV Research and Treatment 24
- Immunology top 5%
- Immune Cell Function and Interaction 9
- Immune cells in cancer 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 10
- Epidemiology top 10%
-
- Research on Leishmaniasis Studies 5
-
- Neuropeptides and Animal Physiology 5
-
- Inflammasome and immune disorders 4
- Co-authors
- Tamás OraveczMichael A. NorcrossGregory RoderiquezMasaki YanagishitaElvira M. SaraivaJairo R. TemerozoPaolo LussoP W Berman
- Partner nations
- BrazilUnited StatesSao Tome and Principe
In The Last Decade
Dumith Chequer Bou‐Habib
58 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Virology 720
- Immunology 681
- Infectious Diseases 568
- Epidemiology 428
- Public Health, Environmental and Occupational Health 350
Countries citing papers authored by Dumith Chequer Bou‐Habib
This map shows the geographic impact of Dumith Chequer Bou‐Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dumith Chequer Bou‐Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dumith Chequer Bou‐Habib more than expected).
Fields of papers citing papers by Dumith Chequer Bou‐Habib
This network shows the impact of papers produced by Dumith Chequer Bou‐Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dumith Chequer Bou‐Habib. The network helps show where Dumith Chequer Bou‐Habib may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dumith Chequer Bou‐Habib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 13 | |
| 6 | 2019 | 13 | |
| 7 | 2017 | 6 | |
| 8 | 2013 | 22 | |
| 9 | 2012 | 37 | |
| 10 | 2010 | 34 | |
| 11 | 2009 | 9 | |
| 12 | 2008 | 15 | |
| 13 | 2007 | 6 | |
| 14 | 2006 | 39 | |
| 15 | 2006 | 16 | |
| 16 | 2003 | 2 | |
| 17 | 2001 | 161 | |
| 18 | 2001 | 11 | |
| 19 | 2000 | 63 | |
| 20 | 1995 | 207 |
About Dumith Chequer Bou‐Habib
Dumith Chequer Bou‐Habib is a scholar working on Virology, Immunology and Infectious Diseases, having authored 58 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (10 papers), Immune Cell Function and Interaction (9 papers), Research on Leishmaniasis Studies (5 papers), Neuropeptides and Animal Physiology (5 papers), Immune cells in cancer (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Virology (720 citations), Immunology (681 citations) and Infectious Diseases (568 citations). Dumith Chequer Bou‐Habib has collaborated with scholars based in Brazil, United States and Sao Tome and Principe. Frequent co-authors include Tamás Oravecz, Michael A. Norcross, Gregory Roderiquez, Masaki Yanagishita, Elvira M. Saraiva, Jairo R. Temerozo, Paolo Lusso, P W Berman, H Mostowski and Vincent Hascall. Their work appears in journals such as Nature Medicine, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.